InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by LaBarre Michael J., Chief Technology Officer. Officer active across 1 company, notably Halozyme Therapeutics, INC.. Aggregated, 41 reports have been published. Split: 0 buy · 7 sells. Total volume traded: €2.7m. History available since 3 May 2021. The latest transaction was disclosed on 25 February 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to LaBarre Michael J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
9,300 shares@ US$58.0077.8% of flowCommon StockSEC:0001415889-25-005899:0
4,747 shares0Common StockSEC:0001415889-25-005311:0
3,386 shares0Common StockSEC:0001415889-25-004509:0
5,509 shares@ US$16.651.3% of flowCommon StockSEC:0001415889-24-025233:0
10,000 shares@ US$16.652.3% of flowCommon StockSEC:0001415889-24-023657:0
5,580 shares@ US$18.411.4% of flowCommon StockSEC:0001415889-24-022363:0
10,000 shares@ US$16.652.2% of flowCommon StockSEC:0001415889-24-021850:0
10,000 shares@ US$8.111.1% of flowCommon StockSEC:0001415889-24-020055:0
10,000 shares@ US$8.111.1% of flowCommon StockSEC:0001415889-24-017625:0
10,000 shares@ US$8.111.1% of flowCommon StockSEC:0001415889-24-014123:0
10,000 shares@ US$8.111.1% of flowCommon StockSEC:0001415889-24-011058:0
8,436 shares@ US$12.071.4% of flowCommon StockSEC:0001415889-24-009158:0
10,000 shares@ US$12.071.7% of flowCommon StockSEC:0001415889-24-007825:0
10,000 shares@ US$39.9465.5% of flowCommon StockSEC:0001415889-24-005756:0
6,112 shares0Common StockSEC:0001415889-24-004477:0
3,386 shares0Common StockSEC:0001415889-24-004187:0
8,133 shares0Common StockSEC:0001415889-24-003529:0
10,000 shares@ US$12.071.7% of flowCommon StockSEC:0001415889-24-001520:0
8,533 shares@ US$13.811.6% of flowCommon StockSEC:0001415889-23-016423:0
8,292 shares@ US$13.811.6% of flowCommon StockSEC:0001415889-23-015195:0
10,000 shares@ US$19.982.8% of flowCommon StockSEC:0001415889-23-014366:0
10,000 shares@ US$19.984.1% of flowCommon StockSEC:0001415889-23-013397:0
1,925 shares@ US$18.410.5% of flowCommon StockSEC:0001415889-23-012570:0
10,000 shares@ US$18.412.5% of flowCommon StockSEC:0001415889-23-011318:0
10,000 shares@ US$18.412.5% of flowCommon StockSEC:0001415889-23-010180:0
25 of 41 declarations
About LaBarre Michael J.
LaBarre Michael J. is Senior Vice President, Chief Technical Officer at Halozyme Therapeutics, INC. Across the 41 filings recorded, the sampled recent filings from 2021-05-03 to 2025-02-27 show EUR 0 in purchases and EUR 2712426 in sales, with Levée d'options as the most frequent transaction nature.
